Tamsulosin Hydrochloride Capsule
Product Images NDC 0904-7383

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 0904-7383). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (F8302a6e B8da 4931 A279 B49e37943816 00)

Tamsulosin Hydrochloride 0.4 mg oral capsules in unit dose packaging by Major Pharmaceuticals. The label shows the product name, strength, dosage form, and NDC 0904-7383-61. It includes directions to dispense with patient information leaflet, storage instructions, quantity of 100 capsules (10 x 10), distributor information, and a barcode. The label highlights the product is for prescription use only.*

FDA Label Image

Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n=8) (Tamsulosin Fig1)

A line graph showing mean plasma concentrations of Tamsulosin Hydrochloride over 36 hours following single-dose administration of 0.4 mg capsules under fed and fasted conditions in 8 subjects. The graph plots plasma concentration (ng/mL) on the y-axis against time in hours on the x-axis, depicting higher peak concentration under fasted versus fed conditions.*

FDA Label Image

Figure 2a Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 1 (Tamsulosin Fig2)

A line graph showing mean change from baseline in total AUA symptom score over a 13-week treatment period plus LOCF, comparing three treatments: 0.8 mg and 0.4 mg doses of Tamsulosin Hydrochloride, and placebo. The y-axis represents mean change, and the x-axis represents duration of treatment in weeks, with sample sizes noted below each time point. Both active treatments show greater symptom score reduction than placebo over time.*

FDA Label Image

Figure 2b Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 2 (Tamsulosin Fig3)

A line graph titled 'Figure 2B Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 2' showing mean change in symptom score over a 13-week treatment period. The x-axis represents duration of treatment in weeks, and the y-axis represents mean change. Three lines compare treatments: 0.8 mg and 0.4 mg doses of Tamsulosin Hydrochloride, and placebo. The graph includes sample sizes at various weeks and notes last observation carried forward (LOCF) data.*

FDA Label Image

Figure 3a Mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Tamsulosin Fig4)

Line graph illustrating the mean change in peak urine flow rate (mL/sec) over a 13-week treatment duration for three groups: 0.8 mg dosage, 0.4 mg dosage, and placebo. The graph shows trends in mean change with time points labeled from baseline to last observation carried forward (LOCF), comparing the three groups across the study period.*

FDA Label Image

Figure 3b Mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Tamsulosin Fig5)

A line graph titled 'Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 2' showing treatment effects over time in weeks. The x-axis represents the duration of treatment from 0 to 13 weeks and LOCF, while the y-axis shows mean change in mL/sec from 0 to 3. Three treatment groups are depicted: 0.8 mg, 0.4 mg, and placebo, each indicated by different line styles and markers. The graph illustrates differences in urine flow rate increase among treatments through the study duration.*

FDA Label Image

Chemical Structure (Tamsulosin Str)

Chemical structure of Tamsulosin Hydrochloride. The diagram shows the molecular structure including aromatic rings, sulfur, oxygen, nitrogen, and hydrochloride components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.